drugset / Trial / NCT01109212
The Effects of Bindarit in Diabetic Nephropathy
Phase 2
Completed
100 enrolled
Angelini Pharma
Mario Negri Institute for Pharmacological Research · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether bindarit is effective to reduce albuminuria, compared to placebo, in nephropathic patients treated with irbesartan, as a background therapy.
Timeline
- Start
- 2007-03
- Primary completion
- 2008-11
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bindarit | Small molecule | 600 mg | — |